Measured by its ability to cleave a colorimetric peptide substrate, 1O-hexadecyl-2-deoxy-2-thio Sacetylsnglyceryl-3-phosphoryl choline (2- Thio-PAF), in the presence of 5, 5’Dithiobis(2-nitrobenzoic acid) (DTNB). The specific activity is >5000 pmoles/min/μg.
Modulates the action of platelet-activating factor (PAF) by hydrolyzing the sn-2 ester bond to yield the biologically inactive lyso-PAF. Has a specificity for substrates with a short residue at the sn-2 position. It is inactive against long-chain phospholipids.
Measured by its ability to cleave a colorimetric peptide substrate, 1O-hexadecyl-2-deoxy-2-thio Sacetylsnglyceryl-3-phosphoryl choline (2- Thio-PAF), in the presence of 5, 5’Dithiobis(2-nitrobenzoic acid) (DTNB). The specific activity is >5000 pmoles/min/μg.
It is recommended that sterile water be added to the vial to prepare a stock solution of 0.27mg/mL.
储存条件
-20°C储存,避免反复冻融
运输条件
超低温运输
稳定性与储存
收到后在无菌条件下保存,温度为 -20℃ 至 -80℃。收货后建议分装。避免冷冻/解冻循环。
图片
Recombinant Human PLA2G7 Protein (rp150291) - Enzyme Activity Measured by its ability to cleave a colorimetric peptide substrate, 1-O-hexadecyl-2-deoxy-2-thio-S-acetyl-sn-glyceryl-3-phosphorylcholine (2-Thio-PAF) (T334670), in the presence of 5,5’Dithio-bis(2-nitrobenzoic acid) (DTNB) (D425581). The specific activity is >5,000 pmol/min/ug, as measured under the described condition.
Recombinant Human PLA2G7 Protein (rp150291) - SDS-PAGE 3 μg/lane of Recombinant Human PLA2G7 Protein was resolved with SDS-PAGE under reducing (R) and non-reducing (N) conditions and visualized by Coomassie® Blue staining, showing a band at 54.2 kDa.